Early to mid-term outcomes of the custom-made 3D-printed triflange acetabular component (aMace) : the largest UK dual-centre study.
- 1Wrightington Hospital, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
- 2Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK.
- 3Mersey and West Lancashire Teaching Hospitals NHS Foundation Trust, Whiston Hospital, Prescot, UK.
Abstract
Aims
Various techniques have been described to manage massive acetabular bone loss in revision hip arthroplasty. The aMace system has gained popularity due to its custom design, which aims to restore the hip centre of rotation and provide initial mechanical stability in cases of large, non-contained defects. This study aimed to assess the short- and mid-term outcomes of patients who underwent revision surgery using the aMace system.Methods
A retrospective review was conducted of all patients who underwent aMace implantation at two revision centres between June 2013 and October 2022, with a minimum follow-up of 12 months. Data collected included demographic details, indications for surgery, bone loss classification, reconstruction details, reoperations, complications, and functional outcomes.Results
A total of 52 patients underwent revision surgery, with a median follow-up of 51 months (IQR 36 to 72). The mean age was 72.9 years (40 to 87), and 86.5% (45/52) of patients were female. The mean BMI was 25.3 kg/m² (18.2 to 34.7), and the mean American Society of Anesthesiologists grade was III. Most patients had Paprosky type 3B 65.3% (34/52) or 3A 34.6% (18/52) defects. The main indications for revision were aseptic loosening 69.2% (36/52), infection 15.3% (8/52), and periprosthetic fracture 13.4% (7/52). Single-stage revision was performed in 76.9% (40/52), and 67.3% (35/52) underwent both cup and femoral component revision. Dual-mobility bearings were used in 76.9% (40/52) of cases, including 90% (36/40) of single-stage revisions, and 86.5% (45/52) had a metal-on-polyethylene articulation. No aMace components were revised. The 30-day mortality rate was 1.9% (1/52). The overall reoperation rate was 5.7% (3/52), primarily for periprosthetic femoral fracture and dislocation. Leg length discrepancy occurred in 9.6% (5/52). Two cases of sciatic nerve palsy were transient and resolved during follow-up. Statistically significant improvements in pain and mobility were observed (p < 0.001).Conclusion
Our findings support the aMace system for significant acetabular bone loss and pelvic discontinuity, with satisfactory mid-term outcomes and low complications. We recommend these procedures in specialist centres with multidisciplinary team involvement.
Related
- Comparing Short-Term Clinical Outcomes and Survivorship of Complex Revision Total Hip Arthroplasty: Custom Triflange Acetabular Implants Vs Standard Cage Reconstruction
- Association of S2 Alar–Iliac Versus S1-Only Fixation with Spinopelvic Mobility and Acetabular Component Orientation in Total Hip Arthroplasty: A Standing–Sitting EOS Study
- Patient-specific management in high-risk revision total hip arthroplasty: mid-term outcomes of a next-generation constrained acetabular liner.
- Comparative long-term outcomes of kidney transplantation from donors with isolated microscopic hematuria and thin basement membrane disease versus donors with isolated microscopic hematuria and normal histology: the largest cohort analysis to date.
- Multifactorial nutritional and metabolic risk profiles for behavioral outcomes in Chinese children: a cross-sectional study at a Health Management Center using explainable machine learning and principal component analysis
BibTeX
@article{khaled2026early,
title = {{Early to mid-term outcomes of the custom-made 3D-printed triflange acetabular component (aMace) : the largest UK dual-centre study.}},
author = {Ahmad S Khaled and Mehnoor Khaliq and Jonathan Barrow and Tariq Adam Kwaees and Nikhil Shah and Henry Wynn Jones and Tim Paul Harrison},
journal = {Bone \& joint open},
year = {2026},
month = oct,
doi = {10.1302/2633-1462.710.bjo-2026-0043.r1},
url = {https://europepmc.org/article/MED/42906911},
note = {CC BY-ND},
}
RIS
TY - JOUR
TI - Early to mid-term outcomes of the custom-made 3D-printed triflange acetabular component (aMace) : the largest UK dual-centre study.
AU - Ahmad S Khaled
AU - Mehnoor Khaliq
AU - Jonathan Barrow
AU - Tariq Adam Kwaees
AU - Nikhil Shah
AU - Henry Wynn Jones
AU - Tim Paul Harrison
PY - 2026
DA - 2026/10/22
JO - Bone & joint open
DO - 10.1302/2633-1462.710.bjo-2026-0043.r1
UR - https://europepmc.org/article/MED/42906911
AB - Aims Various techniques have been described to manage massive acetabular bone loss in revision hip arthroplasty. The aMace system has gained popularity due to its custom design, which aims to restore the hip centre of rotation and provide initial mechanical stability in cases of large, non-contained defects. This study aimed to assess the short- and mid-term outcomes of patients who underwent revision surgery using the aMace system.Methods A retrospective review was conducted of all patients who underwent aMace implantation at two revision centres between June 2013 and October 2022, with a minimum follow-up of 12 months. Data collected included demographic details, indications for surgery, bone loss classification, reconstruction details, reoperations, complications, and functional outcomes.Results A total of 52 patients underwent revision surgery, with a median follow-up of 51 months (IQR 36 to 72). The mean age was 72.9 years (40 to 87), and 86.5% (45/52) of patients were female. The mean BMI was 25.3 kg/m² (18.2 to 34.7), and the mean American Society of Anesthesiologists grade was III. Most patients had Paprosky type 3B 65.3% (34/52) or 3A 34.6% (18/52) defects. The main indications for revision were aseptic loosening 69.2% (36/52), infection 15.3% (8/52), and periprosthetic fracture 13.4% (7/52). Single-stage revision was performed in 76.9% (40/52), and 67.3% (35/52) underwent both cup and femoral component revision. Dual-mobility bearings were used in 76.9% (40/52) of cases, including 90% (36/40) of single-stage revisions, and 86.5% (45/52) had a metal-on-polyethylene articulation. No aMace components were revised. The 30-day mortality rate was 1.9% (1/52). The overall reoperation rate was 5.7% (3/52), primarily for periprosthetic femoral fracture and dislocation. Leg length discrepancy occurred in 9.6% (5/52). Two cases of sciatic nerve palsy were transient and resolved during follow-up. Statistically significant improvements in pain and mobility were observed (p < 0.001).Conclusion Our findings support the aMace system for significant acetabular bone loss and pelvic discontinuity, with satisfactory mid-term outcomes and low complications. We recommend these procedures in specialist centres with multidisciplinary team involvement.
SN - 2633-1462
ER -